State Street Corp Soma Logic, Inc. Transaction History

State Street Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.76 - $2.83 $625,600 - $1.01 Million	355,455 Added 12.09%	3,294,807 $8.34 Million
Q3 2023 Nov 14, 2023	SELL	$1.99 - $2.45 $25,828 - $31,798	-12,979 Reduced 0.44%	2,939,352 $7.03 Million
Q2 2023 Aug 14, 2023	BUY	$2.1 - $3.36 $85,839 - $137,343	40,876 Added 1.4%	2,952,331 $6.82 Million
Q1 2023 May 15, 2023	BUY	$2.13 - $3.6 $200,712 - $339,231	94,231 Added 3.34%	2,911,455 $7.42 Million
Q4 2022 Feb 14, 2023	BUY	$2.05 - $3.47 $98,949 - $167,489	48,268 Added 1.74%	2,817,224 $7.07 Million
Q3 2022 Nov 15, 2022	BUY	$0.63 - $5.47 $162,822 - $1.41 Million	258,449 Added 10.29%	2,768,956 $8.03 Million
Q2 2022 Aug 15, 2022	BUY	$4.27 - $8.26 $8.59 Million - $16.6 Million	2,012,256 Added 403.86%	2,510,507 $11.3 Million
Q1 2022 May 16, 2022	BUY	$7.07 - $11.62 $403,350 - $662,932	57,051 Added 12.93%	498,251 $4 Million
Q4 2021 Feb 14, 2022	BUY	$10.49 - $14.28 $4.63 Million - $6.3 Million	441,200 New	441,200 $5.14 Million

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.